The chronic gout market is expected to maintain a stable growth over the forecast period (2025–2034). This growth is fueled by increasing prevalence due to aging populations and cardiometabolic ...

Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Gout (Chronic Refractory) Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access" report has been ...

Please provide your email address to receive an email when new articles are posted on . Patients with gout were more likely than other patients to receive chronic opioids. Female sex, underweight BMI, ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Although rare, hypercalcemia should be treated as a potential threat for patients with from ...

Gout was associated with a 30% higher risk for chronic opioid exposure based on US Veteran's Health Administration data. Patients with gout in the United States are at greater risk for chronic opioid ...

NEW YORK, June 26, 2026 /PRNewswire/ -- According to findings from a National Kidney Foundation (NKF) Scientific Workshop reveal significant gaps in the diagnosis and treatment of gout among people ...

Veterans with gout were 30% more likely to be prescribed chronic opioid therapy than those without gout, with factors such as female sex, underweight BMI, current smoking status, and a higher burden ...

Selecta Biosciences is a biotech firm working on therapies for rare illnesses. SEL-212, its lead product, helps control uric acid levels in chronic refractory gout patients. SEL-212 controls serum ...

Gout is a serious and painful form of arthritis that occurs when there is too much uric acid in the blood. “It is a very common form of arthritis,” says rheumatologist Dr. Orrin Troum. “Pain, redness, ...

JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for inflammatory and metabolic ...

In July 2022, the US Food and Drug Administration (FDA) expanded the labeling of Krystexxa (pegloticase; Horizon Therapeutics), a PEGylated uric acid-specific enzyme, to include coadministration with ...

Patients with gout are more likely than those without to initiate chronic opioid use. Patients with gout are more likely than those without to initiate chronic opioid use, according to study results ...